IMR Press / FBL / Volume 9 / Issue 1 / DOI: 10.2741/1286

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy
Show Less
1 Department of Neurology, The University of Chicago, 5841 S. Maryland Ave/MC2030, Chicago, IL, 60637, USA
Front. Biosci. (Landmark Ed) 2004, 9(1), 939–945; https://doi.org/10.2741/1286
Published: 1 January 2004
Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a term applied to a spectrum of immune-mediated demyelinating neuropathies that are heterogeneous in clinical manifestations and probably in pathogenesis. Although histopathologic studies of CIDP have been complicated by a relapsing course of the inflammatory reaction and its predominance in proximal nerve segments, many clues point to involvement of both cellular and humoral immune factors in the pathogenesis. Uncertainties remain regarding the provoking antigen(s) and location of the initial T cell activation. Breakdown of blood nerve barrier by activated T cells and its cytokines is followed by a local intraneural immune response with recruitment of macrophages and secretion of toxic factors, which cause damage to the myelin and axons. Activated T cells may also induce B cells to produce antibodies against nerve/myelin antigens. This review summarizes our current knowledge of the immunopathogenesis and insight from animal models of CIDP.

Keywords
Nervous system
Disease
Demyelination
Autoimmunity
CIDP
Peripheral Nerves
Pathogenesis
NOD mouse
Review
Share
Back to top